Please provide your email address to receive an email when new articles are posted on . Few adverse events were reported in OPAT containing cefazolin and ceftriaxone. Only 2.7 clinically significant ...
New findings from the RECOVER-Adult cohort study show that 25 routine clinical lab tests are not effective in diagnosing postacute sequelae of SARS-CoV-2 infection, echoing results from earlier ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback